Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813290 | PMC |
| http://dx.doi.org/10.1242/dev.136507 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC.
Clin Lung Cancer
September 2024
Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada.
Article Synopsis
- The AEGEAN trial showed that combining durvalumab with chemotherapy improved treatment outcomes for patients with operable non-small cell lung cancer (NSCLC) compared to chemotherapy alone.
- The MDT-BRIDGE study is investigating neoadjuvant durvalumab plus chemotherapy in patients with stage IIB-IIIB NSCLC to assess their resectability and treatment outcomes post-surgery or chemoradiotherapy.
- The study aims to evaluate the effectiveness of the treatment based on various factors including surgery rates, event-free survival, and safety profiles, with a focus on patients transitioning from resectable to unresectable status.
Eight-channel SiNx microring-resonator based photonic biosensor for label-free fluid analysis in the optical C-band.
Annu Int Conf IEEE Eng Med Biol Soc
July 2023
A lab-on-a-chip multichannel sensing platform for biomedical analysis based on optical silicon nitride (SiNx) microring-resonators (MRR) was established. The resonators were surface functionalized and finally combined with a microfluidic chamber for validation using an avidin-biotin ligand-binding assay. The results with a limit of detection (LOD) of 2.
View Article and Find Full Text PDFImmune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges.
Nat Rev Clin Oncol
October 2023
Oncology Department, CHUV, Lausanne University, Lausanne, Switzerland.
Article Synopsis
- - Therapeutic strategies using immune-checkpoint inhibitors (ICIs) have shown effectiveness in treating advanced non-small-cell lung cancer (NSCLC), enhancing patient survival either alone or with chemotherapy.
- - The challenge lies in applying ICIs in early-stage NSCLC due to difficulties in assessing their efficacy and determining relevant clinical endpoints, although many trials are in progress to explore various treatment combinations.
- - Current trials focus on pathological response as a primary endpoint for neoadjuvant therapies, but there's ongoing uncertainty about how these findings correlate with overall survival, highlighting the need for better patient selection and treatment optimization strategies.
We demonstrate a novel mesh of Mach-Zehnder interferometers (MZIs) for programmable optical processors. We thoroughly analyze the benefits and drawbacks of previously known meshes and compare our newly proposed mesh with these prior architectures, highlighting its unique features and advantages. The proposed mesh, referred to as Bokun mesh, is an architecture that merges the attributes of the prior topologies Diamond and Clements.
View Article and Find Full Text PDFMultielectrode Arrays at Wafer-Level for Miniaturized Sensors Applications: Electrochemical Growth of Ag/AgCl Reference Electrodes.
Sensors (Basel)
July 2023
Fraunhofer Institute for Photonic Microsystems (IPMS), Center Nanoelectronic Technologies (CNT), An der Bartlake 5, 01109 Dresden, Germany.
In this study, a range of miniaturized Ag/AgCl reference electrodes with various layouts were successfully fabricated on wafer-level silicon-based substrates with metallic intermediate layers by precisely controlling the electrochemical deposition of Ag, followed by electrochemical chlorination of the deposited Ag layer. The structure, as well as the chemical composition of the electrode, were characterized with SEM & EDS. The results showed that the chlorination is very sensitive to the applied electric field and background solution.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!